***NON-POLITICAL COVID-19 Discussion Thread***

[JakeF]

A couple of reminders...

Originally Posted by Bwana

Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.

Originally Posted by Dartgod

People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.

We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.

Thanks!

Click here for the original OP:

Spoiler!

Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.

California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM

The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.

“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”

The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.

The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”

Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.

The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.

The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.

A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.

Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.

“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”

It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.

“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”

On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.

“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”

According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.

More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.

But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.

“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”

CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.

Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.

“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”

[jdubya]

My 29 year old son tested positive in December and was down for about a week with mild to moderate symptoms. He has been told he likely has antibodies for a long time and has been told maybe not. He finally said screw it and got his first Phizer yesterday.

[Rain Man]

Originally Posted by O.city

Vast majority of breakthru cases are mild to asymptomatic.

So I wouldn't worry.

That's where I'm at these days. Protection against getting a little bit sick is great, but protection against going into an ICU or dying is the key. I'm not hearing that the breakthrough cases are causing serious illness, so I'm climbing back into the saddle of everyday living.

Originally Posted by lawrenceRaider

The vast majority of break through cases I've seen reported are from the J&J.

That's interesting.

It's really interesting to me to see how the different vaccines are faring. The Pfizer and Moderna vaccines seems to be highly effective and holding up well against the variants.

The J&J seems okay, but we always knew it was going to be less effective.

The Astrazenica and Sinopharm are taking a beating against the variant in the Seychelles. And I read that they're also not effective enough for a population to reach herd immunity using only those vaccines. My hunch is that the J&J falls more closely to this group than to the Pfizer and Moderna.

I wonder how the Russian one is doing.

And Novavax seems to have missed the boat. By the time they have vaccines in syringes we'll be done.

[dirk digler]

Originally Posted by lawrenceRaider

The vast majority of break through cases I've seen reported are from the J&J.

That is what I am thinking. I am glad I got the Pfizer vaccine but I also still do alot of social distancing.

[ghak99]

Originally Posted by dirk digler

That is what I am thinking. I am glad I got the Pfizer vaccine but I also still do alot of social distancing.

At least one of those breakthroughs in Liv was a Moderna.

[NotDonger]

50.3% of adult Americans now fully vaccinated. Pretty impressive, really.

[Bugeater]

Something fishy going on here....

[NotDonger]

The B.1.1.7 (UK) variant is now the most prevalent strain in almost every state. I would post a very informative link, but it seems that I do not have the requisite number of posts yet to post any links.

[displacedinMN]

Ohio gives 1 million dollars to someone that got a vaccine.

Minnesota giving away State Fair tickets. (if they can spare them) Could that be more Minnesotan?

[Bugeater]

Originally Posted by NotDonger

The B.1.1.7 (UK) variant is now the most prevalent strain in almost every state. I would post a very informative link, but it seems that I do not have the requisite number of posts yet to post any links.

You kind of remind me of Donger. Are you sure you're NotDonger?

[NotDonger]

Originally Posted by Bugeater

You kind of remind me of Donger. Are you sure you're NotDonger?

I fail to see why you think that. And no, I’m not sure that I’m NotDonger. On the contrary, I am NotDonger.

[phisherman]

What do you mean by contrary?

[NotDonger]

Originally Posted by phisherman

What do you mean by contrary?

Sorry, I don’t do questions.

[phisherman]

Originally Posted by NotDonger

Sorry, I don’t do questions.

Definitely not Donger.

[Bwana]

Originally Posted by NotDonger

I fail to see why you think that. And no, I’m not sure that I’m NotDonger. On the contrary, I am NotDonger.

Do you wash your legs and how do you feel about having a beer in your garage?

[Fish]

Moderna is 93% effective for teens after just one dose...

Moderna's COVID vaccine safe and highly effective in adolescents, study shows

• No virus cases were observed in the vaccine group after two doses, "resulting in a vaccine efficacy of 100% starting 14 days after the second dose," according to the company.
• The vaccine was found to be 93% effective after one dose.
• Moderna's vaccine is the second to show high efficacy in younger age groups, following Pfizer, which received an FDA emergency use authorization for adolescents earlier this month.